Systemic versus coronary levels of inflammation in acute coronary syndromes

Makoto Suzuki1, Makoto Saito, Takayuki Nagai

  • 1Division of Cardiology, Ehime Prefectural Central Hospital, Ehime, Japan. suzuki-m@mail.netwave.or.jp

Angiology
|October 7, 2006
PubMed

Insights

Systemic and coronary inflammation markers, including high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6), were compared in acute myocardial infarction (AMI) patients. Higher coronary levels of IL-6 and matrix metalloproteinase-9 (MMP-9) were observed, linked to vulnerable plaque morphology.

Area of Science:

  • Cardiology
  • Biochemistry
  • Inflammation Research

Background:

  • Acute coronary syndromes (ACS) involve systemic inflammation.
  • The relationship between systemic and local coronary inflammation in ACS is not fully understood.
  • Understanding this link may offer insights into disease mechanisms and vulnerable plaque characteristics.

Purpose of the Study:

  • To investigate the association between systemic and coronary levels of inflammatory mediators in patients with acute myocardial infarction (AMI).
  • To explore the correlation between systemic inflammatory markers and culprit coronary morphology.
  • To elucidate the role of inflammation in the early phase of AMI.

Main Methods:

  • Analysis of high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and matrix metalloproteinase-9 (MMP-9) in peripheral blood and coronary thrombus samples from 20 AMI patients.
  • Comparison of systemic and coronary inflammatory mediator levels before angioplasty.
  • Intravascular ultrasound was used to assess culprit coronary plaque morphology and its relation to systemic inflammatory markers.

Main Results:

  • Systemic and coronary hs-CRP levels were comparable.
  • Coronary levels of IL-6 and MMP-9 were significantly higher than systemic levels.
  • Systemic hs-CRP correlated with coronary IL-6 levels, and both systemic hs-CRP and IL-6 correlated positively with culprit coronary plaque area.

Conclusions:

  • A link exists between systemic and coronary inflammation in AMI patients.
  • Elevated systemic inflammatory markers are associated with vulnerable coronary plaque morphology.
  • These findings contribute to understanding the inflammatory processes underlying ACS and plaque vulnerability.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...